CrushSCI.com
提供学术论文选刊润色服务
PATHOLOGY & ONCOLOGY RESEARCH 临时占位封面 医学
返回期刊列表

Review Cycle Records

PATHOLOGY & ONCOLOGY RESEARCH

Frontiers SCIE 非OA
2026新锐 4区2025中科院 4区2025 JCR Q2
148.1平均天数
124中位天数
15最短天数
432最长天数
512025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

127 天

Prevalence of APC and PTEN Alterations in Urachal Cancer

作者Nikolett Nagy; Henning Reis; Boris Hadaschik; Christian Niedworok; Orsolya Módos; Attila Szendrői; Krisztina Bíró; Thomas Hager; Thomas Herold; Jason Ablat; Peter C. Black; Krzysztof Okon; Yuri Tolkach; Anita Csizmarik; Csilla Oláh; David Keresztes; Felix Bremmer; Nadine T. Gaisa; Joerg Kriegsmann; Ilona Kovalszky; András Kiss; József Tímár; Marcell A. Szász; Michael Rink; Margit Fisch; Péter Nyirády; Tibor Szarvas

作者单位1. Department of Urology, Semmelweis University, Budapest, Hungary; 2. Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany; 3. Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany; 4. National Institute of Oncology, Budapest, Hungary; 5. Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; 6. Department of Pathomorphology, Jagiellonian University, Cracow, Poland; 7. Institute of Pathology, University of Bonn, Bonn, Germany; 8. Institute of Pathology, University of Göttingen, Göttingen, Germany; 9. Institute of Pathology, RWTH Aachen University, Aachen, Germany; 10. Cytology and Molecular Diagnostics Trier, Center for Histology, Trier, Germany; 11. 1st Institute of Pathology and Expreimental Cancer Research, Semmelweis University, Budapest, Hungary; 12. 2nd Department of Pathology, Semmelweis University, Budapest, Hungary; 13. Cancer Center, Semmelweis University, Budapest, Hungary; 14. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

PDF源文件 DOI 网页
15 天

Grade I, II and III Follicular Lymphomas Express Ig V H Genes with Different Patterns of Somatic Mutation

作者Balázs Csernus; Botond Timár; Zsolt Fülöp; András Matolcsy

作者单位1. 1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary; 2. Department of Laboratory Medicine, Karolinska Institute, Solna, Sweden

PDF源文件 DOI 网页
432 天

The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers

作者Mehmet Zengin; Suat Benek

作者单位1. Kırıkkale University, Department of Pathology, Kırıkkale, Turkey; 2. Beylikdüzü State Hospital, Department of General Surgery, Istanbul, Turkey

PDF源文件 DOI 网页
40 天

Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology

作者Evangelos Tsiambas; Aristeidis Chrysovergis; Vasileios Papanikolaou; Nicholas Mastronikolis; Vasileios Ragos; Nikolaos Kavantzas; Andreas C. Lazaris; Efstratios Patsouris; Christos Riziotis; Minas Paschopoulos; Efthymios Kyrodimos

作者单位1. Department of Cytology, VA Hospital (NIMTS), Athens, Greece; 2. Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 3. Department of CME, Harvard Medical School, Boston, USA; 4. 1st ENT Department, Hippocration Hospital, National and Kapodistrian, University of Athens, Athens, Greece; 5. Department of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Patras, Greece; 6. Department of Maxillofacial Surgery, School of Health Sciences, University of Ioannina, Ioannina, Greece; 7. Theoretical and Physical Chemistry Institute, Photonics for Nanoapplications Laboratory, National Hellenic Research Foundation, Athens, Greece; 8. Department of Obstetrics and Gynaecology, School of Health Sciences, University of Ioannina, Ioannina, Greece

PDF源文件 DOI 网页
74 天

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy

作者Anita Sejben; Renáta Kószó; Zsuzsanna Kahán; Gábor Cserni; Tamás Zombori

作者单位1. Department of Pathology, Faculty of Medicine, University of Szeged, Szeged, Hungary; 2. Department of Oncotherapy, University of Szeged, Szeged, Hungary; 3. Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary

PDF源文件 DOI 网页
121 天

Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma

作者Hulya Sahin Ozkan; Mustafa Umit Ugurlu; Perran Fulden Yumuk; Handan Kaya

作者单位1. Department of Pathology, Marmara University School of Medicine, Pendik Research and Training Hospital, Istanbul, Turkey; 2. Department of General Surgery, Marmara University School of Medicine, Pendik Research and Training Hospital, Istanbul, Turkey; 3. Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Pendik Research and Training Hospital, Istanbul, Turkey

PDF源文件 DOI 网页
388 天

Expression of SIRT1 , SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer

作者Bojana Uzelac; Ana Krivokuca; Mirjana Brankovic-Magic; Zvonko Magic; Snezana Susnjar; Zorka Milovanovic; Gordana Supic

作者单位1. Institute for Medical Research, Military Medical Academy, Belgrade, Serbia; 2. Medical Faculty of Military Medical Academy, University of Defense, Belgrade, Serbia; 3. Institute for Oncology and Radiology of Serbia, Belgrade, Serbia

PDF源文件 DOI 网页
131 天

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

作者Christian Bernreuther; Ferdous Daghigh; Katharina Möller; Claudia Hube-Magg; Maximilian Lennartz; Florian Lutz; Sebastian Dwertmann Rico; Christoph Fraune; David Dum; Andreas M. Luebke; Till Eichenauer; Christina Möller-Koop; Thorsten Schlomm; Corinna Wittmer; Hartwig Huland; Hans Heinzer; Markus Graefen; Alexander Haese; Eike Burandt; Maria Christina Tsourlakis; Till S. Clauditz; Doris Höflmayer; Jakob R. Izbicki; Ronald Simon; Guido Sauter; Sarah Minner; Stefan Steurer; Jan Meiners

作者单位1. Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3. Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany; 4. Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

PDF源文件 DOI 网页
135 天

Papillary Endothelial Hyperplasia (Masson Tumor) of the Hand. Surgical and Pathological Consideration from Seven Cases Using New Vascular Markers

作者Bernadett Bettina Patai; Nora Peterfy; Noemi Szakacs; Zoltan Sapi; Judit Reka Hetthessy

作者单位1. Department of Traumatology, Military Health Centre, Budapest, Hungary; 2. Department of Traumatology and Hand surgery, Saint John’s Hospital, Budapest, Hungary; 3. Department of Orthopedics, Semmelweis University, Budapest, Hungary; 4. First Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

PDF源文件 DOI 网页
18 天

Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer

作者Zsuzsanna Nemeth; Wouter Wijker; Zsolt Lengyel; Erika Hitre; Katalin Borbely

作者单位1. Chemotherapy B and Clinical Pharmacological Department of National Institute of Oncology, Budapest, Hungary; 2. Oncology Department of Szent Margit Hospital, Budapest, Hungary; 3. Auxiliis Pharma Ltd, Budapest, Hungary; 4. Pozitron Diagnostic Ltd, Budapest, Hungary; 5. PET Ambulatory Department of National Institute of Oncology, Budapest, Hungary

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。